These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29520269)

  • 1. Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during
    Garand M; Goodier M; Owolabi O; Donkor S; Kampmann B; Sutherland JS
    Front Immunol; 2018; 9():257. PubMed ID: 29520269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
    Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
    Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigens of
    Choreño-Parra JA; Jiménez-Álvarez LA; Muñoz-Torrico M; Ramírez-Martínez G; Jiménez-Zamudio LA; Salinas-Lara C; García-Latorre EA; Zúñiga J
    Front Immunol; 2020; 11():582414. PubMed ID: 33117393
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mpande CAM; Steigler P; Lloyd T; Rozot V; Mosito B; Schreuder C; Reid TD; Bilek N; Ruhwald M; Andrews JR; Hatherill M; Little F; Scriba TJ; Nemes E
    Front Immunol; 2021; 12():712480. PubMed ID: 34526988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological basis of early clearance of Mycobacterium tuberculosis infection: the role of natural killer cells.
    Abebe F
    Clin Exp Immunol; 2021 Apr; 204(1):32-40. PubMed ID: 33315236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis.
    Choreño-Parra JA; Weinstein LI; Yunis EJ; Zúñiga J; Hernández-Pando R
    Front Immunol; 2020; 11():226. PubMed ID: 32117325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Human NK Cell Phenotypes and Functional Responses to
    Harris LD; Khayumbi J; Ongalo J; Sasser LE; Tonui J; Campbell A; Odhiambo FH; Ouma SG; Alter G; Gandhi NR; Day CL
    Front Cell Infect Microbiol; 2020; 10():120. PubMed ID: 32266170
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.
    Johnson DF; Malone LL; Zalwango S; Mukisa Oketcho J; Chervenak KA; Thiel B; Mayanja-Kizza H; Stein CM; Boom WH; Lancioni CL;
    PLoS One; 2014; 9(5):e96613. PubMed ID: 24796677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy.
    Resende Co T; Hirsch CS; Toossi Z; Dietze R; Ribeiro-Rodrigues R
    Clin Exp Immunol; 2007 Jan; 147(1):45-52. PubMed ID: 17177962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
    Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
    Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.
    Devalraju KP; Neela VSK; Krovvidi SS; Vankayalapati R; Valluri VL
    PLoS One; 2021; 16(9):e0257185. PubMed ID: 34516566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis.
    Choreño-Parra JA; Jiménez-Álvarez LA; Maldonado-Díaz ED; Cárdenas G; Fernández-Lopez LA; Soto-Hernandez JL; Muñoz-Torrico M; Ramírez-Martínez G; Cruz-Lagunas A; Vega-López A; Domínguez-López ML; Sánchez-Garibay C; Guadarrama-Ortíz P; Giono S; Jiménez-Zamudio LA; Khader SA; García-Latorre EA; Salinas-Lara C; Zúñiga J
    J Immunol Res; 2021; 2021():5517856. PubMed ID: 34007850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease.
    Gindeh A; Owolabi O; Donkor S; Sutherland JS
    Tuberculosis (Edinb); 2020 Sep; 124():101978. PubMed ID: 32781412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
    Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
    PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim-3 pathway affects NK cell impairment in patients with active tuberculosis.
    Wang F; Hou H; Wu S; Tang Q; Huang M; Yin B; Huang J; Liu W; Mao L; Lu Y; Sun Z
    Cytokine; 2015 Dec; 76(2):270-279. PubMed ID: 26050547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.
    Giacoia-Gripp CBW; Cazote ADS; da Silva TP; Sant'Anna FM; Schmaltz CAS; Brum TS; de Matos JA; Silva J; Benjamin A; Pilotto JH; Rolla VC; Morgado MG; Scott-Algara D
    Front Immunol; 2019; 10():1800. PubMed ID: 31456797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.
    White MJ; Nielsen CM; McGregor RH; Riley EH; Goodier MR
    Immunology; 2014 May; 142(1):140-50. PubMed ID: 24843874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB.
    Nemes E; Khader SA; Swanson RV; Hanekom WA
    Front Immunol; 2020; 11():1452. PubMed ID: 32793199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis.
    Zahran WA; Ghonaim MM; Koura BA; El-Banna H; Ali SM; El-Sheikh N
    Egypt J Immunol; 2006; 13(1):67-78. PubMed ID: 17974151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.